Intelligence Platform

Patents

Browse 72 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 8338396

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8128924

Methods for using a three-dimensional stromal tissue to promote angiogenesis

Theregen, Inc. · Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7858605

Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7772219

Methods of hormonal treatment utilizing extended cycle contraceptive regimens

TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563593

Method for preparing cell cultures from biological specimens for assaying secreted factors

Precision Therapeutics, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7368279

Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7112415

Method of preparing cell cultures from biological specimens for assaying a response to an

Precision Therapeutics, Inc. · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6900027

Method for preparing cell cultures from biological specimens for chemotherapeutic and othe

Precision Therapeutics, Inc. · Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6887680

Method for preparing cell cultures from biological specimens for chemotherapeutic and othe

Precision Therapeutics, Inc. · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6889145

Three-dimensional model of a Fc region of an IgE antibody and uses thereof

Northwestern University · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6872387

Three-dimensional hydrogel/cell system

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6820011

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6759408

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Jul 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6613792

Treatment of premenstrual syndrome and menopause

Designed Nutritional Products, Inc. · Granted Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6544970

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6503939

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jan 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6498154

Cyclic regimens using quinazolinone and benzoxazine derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6462032

Cyclic regimens utilizing indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6444668

Combination regimens using progesterone receptor modulators

Ligand Pharmaceuticals Incorporated · Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6399593

Cyclic regimens using cyclic urea and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6380178

Cyclic regimens using cyclocarbamate and cyclic amide derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6329416

Combination regimens using 3,3-substituted indoline derivatives

Ligand Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6319912

Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides

Ligand Pharmaceuticals Incorporated · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)